**Core Concept**
The question pertains to antiretroviral therapy (ART) for HIV, a complex interplay of viral replication, host immune response, and pharmacological intervention. ART aims to suppress HIV replication, restore the immune system, and prevent disease progression.

**Why the Correct Answer is Right**
The FDA-approved drug for HIV is a combination of antiretroviral medications that target different stages of the HIV life cycle. The first FDA-approved drug for HIV was **Zidovudine (AZT)**, a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits the viral replication by blocking the reverse transcriptase enzyme. This enzyme is crucial for the conversion of viral RNA into DNA, allowing the virus to integrate into the host genome.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a particular FDA-approved drug for HIV. While antiretroviral therapy is a broad category, the question seeks a specific medication.
**Option B:** This option is incorrect because it is not a recognized FDA-approved drug for HIV. This distractor may be a fictional or hypothetical medication.
**Option C:** This option is incorrect because it does not accurately represent a FDA-approved drug for HIV. While some medications may have off-label uses or be in development for HIV, this option is not a recognized treatment.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that combination therapy is key in HIV management, with a combination of at least two or three different classes of antiretroviral medications to effectively suppress viral replication.

**Correct Answer: Zidovudine (AZT)**